|
⚲
|
| Keyboard |
| Mark Wagstaff | |
|---|---|
| Firm | |
| Address | 535 W Research Center Blvd Suite 135 Fayetteville, AR 72701 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| VIN-59 Enhance Health LLC | 021-592354 | Executive Officer | 0.0 M of 0.0 M |
||
| VIN-40 Akeso Biomedical LLC | 021-489794 | Executive Officer | 0.0 M of 0.5 M |
||
| VIN-41 Neurexis Therapeutics LLC | 021-489806 | Executive Officer | 0.0 M of 0.5 M |
||
| VIN-38 Vixiar Medical LLC | 021-483244 | Executive Officer | 0.1 M of 0.5 M |
||
| Cellia Science Inc | 021-482802 | Executive Officer | 0.1 M of 0.5 M |
||
| VIN-37 Solaris Vaccines LLC | 021-479722 | Executive Officer | 0.0 M of 0.5 M |
||
| Solenic Medical Inc | 021-468979 | Executive Officer | 3.7 M of 7.0 M |
||
| Cellia Science Inc | 021-464459 | Executive Officer | 0.2 M of 0.2 M |
||
| Cardiowise Inc | 021-436971 | Executive Officer | 0.3 M of 1.0 M |
||
| Cardiowise Inc | 021-363703 | Executive Officer | 0.3 M of 1.0 M |
||
| VIN-10 Zebra Analytix LLC | 021-348615 | Executive Officer | 0.1 M of 0.5 M |
||
| VIN-11 SFC Fluidics LLC | 021-348616 | Executive Officer | 0.0 M of 0.5 M |
||
| VIN-9 NOB Hill Therapeutics LLC | 021-348614 | Executive Officer | 0.1 M of 0.5 M |
||
| VIN-7 Solenic Medical LLC | 021-335336 | Executive Officer | 0.2 M of 0.2 M |
||
| Akeso Biomedical Inc | 021-312793 | Executive Officer | 1.0 M of 2.5 M |
||
| Navitas Capital Management LLC | |||||
| Navitas Capital IV SG LP | 021-483253 | Executive Officer | 0.0 M of 0.5 M |
5.8 M | |